Recent technical improvements have led to a decrease of scanning duration in computed tomography and opened the doors to cardiac imaging, particularly for coronary applications. Recently, large studies have compared anatomical and functional testing in coronary artery disease, showing at least similar results in terms of long-term cardiovascular mortality and morbidity. Adding functional to anatomical information aims to make CT a « one-stop shop » in investigating coronary artery disease.
View Article and Find Full Text PDFEur Heart J Qual Care Clin Outcomes
August 2022
Although the management of ischaemic heart disease has markedly improved over the last decades, left ventricular thrombus remains a serious finding in patients with myocardial infarction. Routine diagnostic detection of left ventricular thrombus relies mainly on echocardiography; however, cardiac magnetic resonance has emerged as a method with higher diagnostic accuracy, while cardiac computed tomography angiography represents a valuable alternative modality. To reduce the left ventricular thrombus-associated morbidity and mortality, optimal selection of anticoagulation is warranted after balancing the risk of bleeding.
View Article and Find Full Text PDFBackground: The first CE-approved bioresorbable vascular scaffold (BVS) is effective at treating simple lesions and stable coronary artery disease, but it has yet to be assessed versus the best-in-class drug-eluting stents (DES).
Objectives: This study sought to compare the performance of a BVS with that of everolimus-eluting stents (EES) and biolimus-eluting stents (BES) in all-comer patients.
Methods: The EVERBIO II (Comparison of Everolimus- and Biolimus-Eluting Stents With Everolimus-Eluting Bioresorbable Vascular Scaffold Stents II) trial was a single-center, assessor-blinded study of 240 patients randomly assigned in a 1:1:1 ratio to EES, BES, or BVS.